ES8403723A1 - A process for producing an insulin preparation. - Google Patents
A process for producing an insulin preparation.Info
- Publication number
- ES8403723A1 ES8403723A1 ES520249A ES520249A ES8403723A1 ES 8403723 A1 ES8403723 A1 ES 8403723A1 ES 520249 A ES520249 A ES 520249A ES 520249 A ES520249 A ES 520249A ES 8403723 A1 ES8403723 A1 ES 8403723A1
- Authority
- ES
- Spain
- Prior art keywords
- zinc
- insulin
- preparation
- ions
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A stable, quick-acting insulin preparation is produced by dissolving a zinc-free insulin in an aqueous medium containing monovalent ions, such as sodium ions, but substantially no di- or polyvalent ions, adjusting the pH to the range of 6.9 to 8.0, preferably 7.2 to 7.8, and adding a zinc compound corresponding to 0.5 to 1.0% zinc, preferably 0.7 to 0.9% zinc, based on the weight of insulin. The preparation has a great stability against aggregation at 25 to 37<o>C and therefore lends itself to be used particularly for portable or implantable insulin delivery devices.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK91882 | 1982-03-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES520249A0 ES520249A0 (en) | 1984-04-16 |
ES8403723A1 true ES8403723A1 (en) | 1984-04-16 |
Family
ID=8099004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES520249A Expired ES8403723A1 (en) | 1982-03-03 | 1983-03-02 | A process for producing an insulin preparation. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0102976A1 (en) |
ES (1) | ES8403723A1 (en) |
WO (1) | WO1983003054A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI78616C (en) * | 1982-02-05 | 1989-09-11 | Novo Industri As | Process for preparing an infused stabilized insulin solution having an elevated zinc content |
US5597893A (en) * | 1994-10-31 | 1997-01-28 | Eli Lilly And Company | Preparation of stable insulin analog crystals |
DE19733651A1 (en) * | 1997-08-04 | 1999-02-18 | Boehringer Ingelheim Pharma | Aqueous aerosol preparations containing biologically active marrow molecules and processes for producing corresponding aerosols |
AU2002300833B2 (en) * | 1997-08-04 | 2007-05-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols |
RU2251426C1 (en) * | 2003-09-18 | 2005-05-10 | Цыганков Владимир Владимирович | Method for obtaining insulin out of natural source and insulin |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
EP2414560B1 (en) | 2009-03-31 | 2013-10-23 | Boehringer Ingelheim International GmbH | Method for coating a surface of a component |
JP5763053B2 (en) | 2009-05-18 | 2015-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Adapter, inhaler and atomizer |
JP5658268B2 (en) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Nebulizer |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2011064164A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2011160932A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2012130757A1 (en) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medical device comprising a container |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2013152894A1 (en) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Atomiser with coding means |
JP6643231B2 (en) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Nebulizer |
EP2835146B1 (en) | 2013-08-09 | 2020-09-30 | Boehringer Ingelheim International GmbH | Nebulizer |
JP6580070B2 (en) | 2014-05-07 | 2019-09-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Container, nebulizer, and use |
PL3139984T3 (en) | 2014-05-07 | 2021-11-08 | Boehringer Ingelheim International Gmbh | Nebulizer |
LT3928818T (en) | 2014-05-07 | 2023-03-27 | Boehringer Ingelheim International Gmbh | Nebulizer and container |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1212679B (en) * | 1957-08-03 | 1966-03-17 | Novo Terapeutisk Labor As | Process for the preparation of insulin solutions |
US3091573A (en) * | 1958-05-12 | 1963-05-28 | Novo Terapeutisk Labor As | Quick acting insulin preparation |
DK116527B (en) * | 1967-03-01 | 1970-01-19 | Nordisk Insulinlab | Process for the preparation of a fast-acting, durable, neutral solution of pure crystalline bovine insulin or bovine insulin which is crystallizable in water by the addition of Zn, or mixtures of bovine insulin and insulin of other origin. |
US3657425A (en) * | 1969-03-12 | 1972-04-18 | Burroughs Wellcome Co | Beef insulin preparations |
US3719655A (en) * | 1969-12-05 | 1973-03-06 | Lilly Co Eli | Process for the crystallization of the ammonium and alkali metal salts in insulin |
US3876623A (en) * | 1973-05-09 | 1975-04-08 | Lilly Co Eli | Process for purifying insulin |
US3878186A (en) * | 1973-05-09 | 1975-04-15 | Lilly Co Eli | Process for purifying insulin |
DK80781A (en) * | 1980-02-29 | 1981-08-30 | Hospital For Sick Children | SOLUTIONS OF POLYPEPTIDES |
-
1983
- 1983-03-02 EP EP19830900834 patent/EP0102976A1/en not_active Withdrawn
- 1983-03-02 ES ES520249A patent/ES8403723A1/en not_active Expired
- 1983-03-02 WO PCT/DK1983/000024 patent/WO1983003054A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES520249A0 (en) | 1984-04-16 |
EP0102976A1 (en) | 1984-03-21 |
WO1983003054A1 (en) | 1983-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8403723A1 (en) | A process for producing an insulin preparation. | |
DK3891A (en) | STABILIZED ENZYME DISPERSION | |
ES8500060A1 (en) | Stabilized insulin preparations | |
ES340956A1 (en) | Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation | |
DK0688165T3 (en) | Herbicide preparation, process for its preparation and activating additive for use therewith | |
ES9100015A1 (en) | An explosive composition stable in storage (Machine-translation by Google Translate, not legally binding) | |
ES8405032A1 (en) | Inclusion compound of Lankacidin-group antibiotic and use thereof. | |
ES471721A1 (en) | Improvement in or relating to a process for producing interferon. | |
ES8501415A1 (en) | Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin | |
KR870003220A (en) | Treatment method of rare earth ore | |
ES8604134A1 (en) | Substituted unsaturated mercaptocarboxylic acids and derivatives as leukotriene antagonists. | |
JPS5534054A (en) | Preparation of globular food | |
JPS5724634A (en) | Deoxydizer composition | |
ES455378A1 (en) | Stabilized hypochlorous acid and hypochlorite solutions | |
GB1462023A (en) | Manufacture of cobalt iii acetylacetonate | |
ES8201521A1 (en) | Derivatives of 2-methylpropionic acid, process for their preparation and pharmaceutical compositions containing them. | |
JPS56109460A (en) | Lead storage battery | |
ES8609219A1 (en) | Diphenylmethylimine derivatives. | |
IE40985L (en) | Insulin preparation. | |
KR860002269A (en) | Process for preparing parenteral solutions | |
GB1111563A (en) | Methods for preparing n-benzyl-n',n"-dimethylguanidine | |
GB8514315D0 (en) | Preparation of aqueous solution | |
JPS52128288A (en) | Glucose isomerase solution | |
GB1139917A (en) | Method of producing water-soluble polyacrylamide | |
JPS5460329A (en) | Scaly zinc powder and coating compound containing it |